Dimensional Fund Advisors LP Grows Position in IQVIA Holdings Inc. (NYSE:IQV)

Dimensional Fund Advisors LP increased its position in shares of IQVIA Holdings Inc. (NYSE:IQVFree Report) by 8.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,104,782 shares of the medical research company’s stock after buying an additional 85,428 shares during the period. Dimensional Fund Advisors LP owned 0.61% of IQVIA worth $255,634,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. AdvisorNet Financial Inc increased its holdings in IQVIA by 327.6% in the 4th quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company’s stock worth $29,000 after acquiring an additional 95 shares in the last quarter. BKM Wealth Management LLC acquired a new position in shares of IQVIA during the 4th quarter worth about $32,000. Activest Wealth Management purchased a new position in IQVIA in the 4th quarter valued at about $35,000. CVA Family Office LLC acquired a new stake in IQVIA in the 4th quarter worth about $43,000. Finally, CoreFirst Bank & Trust purchased a new stake in IQVIA during the 3rd quarter worth approximately $44,000. Hedge funds and other institutional investors own 89.62% of the company’s stock.

IQVIA Trading Down 2.2 %

NYSE:IQV opened at $229.04 on Tuesday. The company has a debt-to-equity ratio of 2.02, a quick ratio of 0.88 and a current ratio of 0.88. IQVIA Holdings Inc. has a 1 year low of $167.42 and a 1 year high of $261.73. The stock has a market capitalization of $41.73 billion, a price-to-earnings ratio of 31.29, a PEG ratio of 2.35 and a beta of 1.52. The stock has a fifty day moving average price of $242.11 and a two-hundred day moving average price of $226.02.

IQVIA (NYSE:IQVGet Free Report) last released its quarterly earnings data on Wednesday, February 14th. The medical research company reported $2.84 EPS for the quarter, topping analysts’ consensus estimates of $2.82 by $0.02. The firm had revenue of $3.87 billion for the quarter, compared to the consensus estimate of $3.80 billion. IQVIA had a net margin of 9.01% and a return on equity of 29.17%. The firm’s revenue was up 3.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.54 earnings per share. As a group, sell-side analysts anticipate that IQVIA Holdings Inc. will post 10.1 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

IQV has been the topic of a number of research analyst reports. SVB Leerink assumed coverage on IQVIA in a research note on Monday, February 26th. They issued an “outperform” rating and a $290.00 price target on the stock. StockNews.com upgraded shares of IQVIA from a “hold” rating to a “buy” rating in a report on Friday, February 16th. Truist Financial dropped their target price on IQVIA from $297.00 to $292.00 and set a “buy” rating for the company in a report on Friday, May 3rd. Leerink Partnrs reiterated an “outperform” rating on shares of IQVIA in a report on Monday, February 26th. Finally, BTIG Research started coverage on shares of IQVIA in a research report on Tuesday, February 13th. They set a “buy” rating and a $285.00 price target on the stock. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $257.57.

Get Our Latest Analysis on IQVIA

Insider Activity at IQVIA

In other news, insider Eric Sherbet sold 1,000 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $241.50, for a total value of $241,500.00. Following the sale, the insider now directly owns 20,836 shares in the company, valued at $5,031,894. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other IQVIA news, insider Ari Bousbib sold 31,678 shares of the business’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $250.53, for a total value of $7,936,289.34. Following the completion of the transaction, the insider now directly owns 796,752 shares in the company, valued at approximately $199,610,278.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Eric Sherbet sold 1,000 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $241.50, for a total transaction of $241,500.00. Following the transaction, the insider now directly owns 20,836 shares of the company’s stock, valued at approximately $5,031,894. The disclosure for this sale can be found here. In the last three months, insiders have sold 41,285 shares of company stock valued at $10,331,003. Insiders own 1.60% of the company’s stock.

About IQVIA

(Free Report)

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Recommended Stories

Institutional Ownership by Quarter for IQVIA (NYSE:IQV)

Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.